Currently, Anthony M. Manning is Chairman of Institute For Biomedical Entrepreneurship, Inc. and Chief Scientific Officer of Momenta Pharmaceuticals, Inc. Dr. Manning is also on the board of Palatin Technologies, Inc. Dr. Manning previously held the position of SVP-Research & Preclinical Development at Aileron Therapeutics, Inc., Vice President & Head-Autoimmune Diseases Research at Biogen, Inc., Head-Research at Celgene Corp., Vice President & Global Head-Inflammation at Roche Pharmaceuticals, Inc., Principal at Signal Pharmaceuticals, Inc. and Vice President at Pharmacia Corp. He received a doctorate from the University of Otago.